ciprofibrate has been researched along with dioctyl adipate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lalwani, ND; Rao, MS; Reddy, JK; Reddy, MK; Usman, MI | 1 |
| Eckl, PM; Reisenbichler, H | 1 |
2 other study(ies) available for ciprofibrate and dioctyl adipate
| Article | Year |
|---|---|
Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
Topics: Adipates; Animals; Catalase; Clofibrate; Clofibric Acid; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Fibric Acids; Liver; Liver Neoplasms, Experimental; Microbodies; Microscopy, Electron; Oxidation-Reduction; Phthalic Acids; Rats; Structure-Activity Relationship | 1986 |
Genotoxic effects of selected peroxisome proliferators.
Topics: Adipates; Animals; Cells, Cultured; Chromosome Aberrations; Clofibric Acid; Female; Fibric Acids; Liver; Microbodies; Micronucleus Tests; Mutagens; Nafenopin; Rats; Rats, Inbred F344; Sister Chromatid Exchange | 1993 |